Chapter/Section Purchase

1 Study Coverage
1.1 Disruptive Behavior Disorders (DBD) Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022) & (US$ Million) Introduction
1.2 Global Disruptive Behavior Disorders (DBD) Outlook 2017 VS 2022 VS 2028
1.2.1 Global Disruptive Behavior Disorders (DBD) Market Size for the Year 2017-2028
1.2.2 Global Disruptive Behavior Disorders (DBD) Market Size for the Year 2017-2028
1.3 Disruptive Behavior Disorders (DBD) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Disruptive Behavior Disorders (DBD) in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Disruptive Behavior Disorders (DBD) Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Disruptive Behavior Disorders (DBD) Market Dynamics
1.4.1 Disruptive Behavior Disorders (DBD) Industry Trends
1.4.2 Disruptive Behavior Disorders (DBD) Market Drivers
1.4.3 Disruptive Behavior Disorders (DBD) Market Challenges
1.4.4 Disruptive Behavior Disorders (DBD) Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Disruptive Behavior Disorders (DBD) by Type
2.1 Disruptive Behavior Disorders (DBD) Market Segment by Type
2.1.1 Stimulants
2.1.2 Non-stimulants
2.2 Global Disruptive Behavior Disorders (DBD) Market Size by Type (2017, 2022 & 2028)
2.3 Global Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2028)
2.4 United States Disruptive Behavior Disorders (DBD) Market Size by Type (2017, 2022 & 2028)
2.5 United States Disruptive Behavior Disorders (DBD) Market Size by Type (2017-2028)
3 Disruptive Behavior Disorders (DBD) by Application
3.1 Disruptive Behavior Disorders (DBD) Market Segment by Application
3.1.1 Conduct Disorder (CD)
3.1.2 Oppositional Defiant Disorder (ODD)
3.2 Global Disruptive Behavior Disorders (DBD) Market Size by Application (2017, 2022 & 2028)
3.3 Global Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2028)
3.4 United States Disruptive Behavior Disorders (DBD) Market Size by Application (2017, 2022 & 2028)
3.5 United States Disruptive Behavior Disorders (DBD) Market Size by Application (2017-2028)
4 Global Disruptive Behavior Disorders (DBD) Competitor Landscape by Company
4.1 Global Disruptive Behavior Disorders (DBD) Market Size by Company
4.1.1 Top Global Disruptive Behavior Disorders (DBD) Companies Ranked by Revenue (2021)
4.1.2 Global Disruptive Behavior Disorders (DBD) Revenue by Player (2017-2022)
4.2 Global Disruptive Behavior Disorders (DBD) Concentration Ratio (CR)
4.2.1 Disruptive Behavior Disorders (DBD) Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Disruptive Behavior Disorders (DBD) in 2021
4.2.3 Global Disruptive Behavior Disorders (DBD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Disruptive Behavior Disorders (DBD) Headquarters, Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022) & (US$ Million) Type
4.3.1 Global Disruptive Behavior Disorders (DBD) Headquarters and Area Served
4.3.2 Global Disruptive Behavior Disorders (DBD) Companies Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Disruptive Behavior Disorders (DBD) Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Disruptive Behavior Disorders (DBD) Market Size by Company
4.5.1 Top Disruptive Behavior Disorders (DBD) Players in United States, Ranked by Revenue (2021)
4.5.2 United States Disruptive Behavior Disorders (DBD) Revenue by Players (2020, 2021 & 2022)
5 Global Disruptive Behavior Disorders (DBD) Market Size by Region
5.1 Global Disruptive Behavior Disorders (DBD) Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Disruptive Behavior Disorders (DBD) Market Size by Region (2017-2028)
5.2.1 Global Disruptive Behavior Disorders (DBD) Market Size by Region: 2017-2022
5.2.2 Global Disruptive Behavior Disorders (DBD) Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Disruptive Behavior Disorders (DBD) Market Size YoY Growth 2017-2028
6.1.2 North America Disruptive Behavior Disorders (DBD) Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Disruptive Behavior Disorders (DBD) Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Disruptive Behavior Disorders (DBD) Market Size YoY Growth 2017-2028
6.3.2 Europe Disruptive Behavior Disorders (DBD) Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Disruptive Behavior Disorders (DBD) Market Size YoY Growth 2017-2028
6.4.2 Latin America Disruptive Behavior Disorders (DBD) Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Disruptive Behavior Disorders (DBD) Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Disruptive Behavior Disorders (DBD) Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Eli Lilly
7.1.1 Eli Lilly Company Details
7.1.2 Eli Lilly Business Overview
7.1.3 Eli Lilly Disruptive Behavior Disorders (DBD) Introduction
7.1.4 Eli Lilly Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
7.1.5 Eli Lilly Recent Development
7.2 Bionomics
7.2.1 Bionomics Company Details
7.2.2 Bionomics Business Overview
7.2.3 Bionomics Disruptive Behavior Disorders (DBD) Introduction
7.2.4 Bionomics Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
7.2.5 Bionomics Recent Development
7.3 Chelsea Therapeutics
7.3.1 Chelsea Therapeutics Company Details
7.3.2 Chelsea Therapeutics Business Overview
7.3.3 Chelsea Therapeutics Disruptive Behavior Disorders (DBD) Introduction
7.3.4 Chelsea Therapeutics Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
7.3.5 Chelsea Therapeutics Recent Development
7.4 Pfizer
7.4.1 Pfizer Company Details
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Disruptive Behavior Disorders (DBD) Introduction
7.4.4 Pfizer Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
7.4.5 Pfizer Recent Development
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Details
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Disruptive Behavior Disorders (DBD) Introduction
7.5.4 Johnson & Johnson Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
7.5.5 Johnson & Johnson Recent Development
7.6 DURECT
7.6.1 DURECT Company Details
7.6.2 DURECT Business Overview
7.6.3 DURECT Disruptive Behavior Disorders (DBD) Introduction
7.6.4 DURECT Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
7.6.5 DURECT Recent Development
7.7 Novartis
7.7.1 Novartis Company Details
7.7.2 Novartis Business Overview
7.7.3 Novartis Disruptive Behavior Disorders (DBD) Introduction
7.7.4 Novartis Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
7.7.5 Novartis Recent Development
7.8 McNeil Pharmaceuticals
7.8.1 McNeil Pharmaceuticals Company Details
7.8.2 McNeil Pharmaceuticals Business Overview
7.8.3 McNeil Pharmaceuticals Disruptive Behavior Disorders (DBD) Introduction
7.8.4 McNeil Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
7.8.5 McNeil Pharmaceuticals Recent Development
7.9 Sunovion Pharmaceuticals
7.9.1 Sunovion Pharmaceuticals Company Details
7.9.2 Sunovion Pharmaceuticals Business Overview
7.9.3 Sunovion Pharmaceuticals Disruptive Behavior Disorders (DBD) Introduction
7.9.4 Sunovion Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
7.9.5 Sunovion Pharmaceuticals Recent Development
7.10 New River Pharmaceuticals
7.10.1 New River Pharmaceuticals Company Details
7.10.2 New River Pharmaceuticals Business Overview
7.10.3 New River Pharmaceuticals Disruptive Behavior Disorders (DBD) Introduction
7.10.4 New River Pharmaceuticals Revenue in Disruptive Behavior Disorders (DBD) Business (2017-2022)
7.10.5 New River Pharmaceuticals Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer